tirzepatide beginner dose Dosing for Weight Loss in Units Zepbound® Tirzepatide Dosage Guide

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus in adults (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

She said compounded tirzepatide has helped change her life dramatically since she began taking it in June, alleviating pain from her autoimmune issues and helping her lose about 52 pounds

Retatrutide is a triple-agonist (GLP-1, GIP, and glucagon receptor) that has shown even more dramatic weight loss results in early trials

Explore the broader landscape